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Abstract
Introduction: Intracranial pressure (ICP) measurement is used to tailor interventions and to assist in formulating the
prognosis for traumatic brain injury patients. Accurate data are therefore essential. The aim of this study was to
verify the accuracy of ICP monitoring systems on the basis of a literature review.
Methods: A PubMed search was conducted from 1982 to 2014, plus additional references from the selected
papers. Accuracy was defined as the degree of correspondence between the pressure read by the catheter and a
reference “real” ICP measurement. Studies comparing simultaneous readings from at least two catheters were
included. Drift was defined as the loss of accuracy over the monitoring period. Meta-analyses of data from the
studies were used to estimate the overall mean difference between simultaneous ICP measurements and their
variability. Individual studies were weighted using both a fixed and a random effects model.
Results: Of 163 articles screened, 83 compared two intracranial catheters: 64 reported accuracy and 37 drift (some
reported both). Of these, 10 and 17, respectively, fulfilled the inclusion criteria for accuracy and zero drift analysis. The
combined mean differences between probes were 1.5 mmHg (95 % confidence interval (CI) 0.7–2.3) with the random
effects model and 1.6 mmHg (95 % CI 1.3–1.9) with the fixed effects model. The reported mean drift over a long
observation period was 0.75 mmHg. No relation was found with the duration of monitoring or differences between
various probes.
Conclusions: This study confirms that the average error between ICP measures is clinically negligible. The random
effects model, however, indicates that a high percentage of readings may vary over a wide range, with clinical
implications both for future comparison studies and for daily care.
Introduction
Intracranial pressure (ICP) monitoring is widely used in
neurointensive care, especially for the management of pa-
tients with traumatic brain injury (TBI). ICP levels are
used to decide interventions, to verify the efficacy of thera-
peutic maneuvers, and in formulating a prognosis. For all
these purposes accurate measurements are essential.
Clinicians rely on numbers provided by different
methods, and generally believe that those numbers reflect
actual ICP with a high degree of accuracy. For instance, a
recent trial on decompressive craniectomy randomized
patients to different treatments when ICP exceeded
20 mmHg [1], assuming that the sensors used ensured a
clear-cut threshold.
In real life, however, ICP measurement is challenging.
A basic assumption is that the ICP read at one point in
the intracranial system properly reflects the average
pressure throughout all other locations. Under normal
conditions the cerebrospinal fluid (CSF) pressure should
in fact be in equilibrium in the whole of the CSF space.
Under pathological conditions (as when CSF circulation
is obstructed or intracranial masses are expanding),
however, ICP cones can develop leading to uneven ICP
levels [2, 3]. Even when ICP is homogeneous in the
whole intracranial space measurements may not all be
accurate, depending on the devices used and the dur-
ation of the measurement [4–6].
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Our hypothesis is that clinically used systems measure
ICP with different degrees of accuracy, not always pro-
viding a precise measure. Therefore, our goal was to
evaluate the accuracy and precision over time (drift) of
different ICP measurements on the basis of a review of
the literature.
Methods
Literature search
A PubMed (http://www.ncbi.nlm.nih.gov/pubmed) search
was made, looking for studies published from January
1982 through November 2014. The following keywords
were searched: “intracranial pressure” AND “Camino”,
“intracranial pressure” AND “Codman”, “intracranial pres-
sure” AND “fluid filled”, “intracranial pressure” AND “tip
transducer”, “intracranial pressure” AND “drift”. The
search was limited to articles in English and animal stud-
ies were included at this stage. Additional articles were
screened through the references listed in the papers ini-
tially selected.
Accuracy
Accuracy was defined as the degree of correspondence
between the pressure read by the catheter and a refer-
ence “real” ICP measurement. In order to assess accur-
acy in vivo, studies comparing simultaneous readings
from at least two catheters were included, divided into
two groups:
Group 1: studies comparing a ventricular fluid-coupled
catheter with external transducer (VFC) with another
type of device. According to the guidelines of the Brain
Trauma Foundation [7], this is the most accurate method
for measuring ICP so we took it as the reference
standard.
Group 2: studies comparing catheters other than VFC.
Some articles included substudies with different sets of
paired readings from probes. These were analyzed as
separate studies.
Studies on intracranial probes located in the epidural,
subdural, or subarachnoid space or comparing infraten-
torial versus supratentorial probes were excluded from
the analysis. Studies were screened for numerical data,
and only those reporting the limits of agreement and
bias (or data from which they could be calculated) were
included. Animal studies were not included in this
analysis.
Zero drift
Drift was defined as the loss of accuracy over the moni-
toring time, a problem related to catheters such as intra-
parenchymal probes that cannot be re-zeroed during
monitoring. In the selected papers drift was assessed by
two methods: a) verifying the pressure read by the cath-
eter at atmospheric pressure once it was removed from
the patient [8, 9]; and b) measuring pressure changes
over time in an artificial hydraulic model [10, 11]. Ani-
mal studies were included in this analysis.
Statistics
Mean ICP differences between the various probes,
standard deviation and limits of agreement were re-
ported in most papers. If these summary measures were
not available, but mean ICP readings per patient were
presented, as read with different probes, we calculated
the mean ICP differences and standard deviations
(Table 1). Studies for which the results were only given
in plots or summary tables were not suitable for the
planned analysis, and therefore they were not included
on the basis of inadequate data reporting (Fig. 1). The
authors of five relevant papers reporting incomplete
information [12–16] were asked to provide the original
data, but this was not accessible (mainly because it was
collected decades ago), and these studies were not
included either.
The limits of agreement between simultaneous ICP
measurements were calculated using the following
formula:
x  t 0:025;n−1ð Þs
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ 1
n
r
where x equals the mean difference, s the standard de-
viation of the differences, and t(0.025, n–1) the value
from Student’s t-distribution corresponding to a two-
sided alpha of 0.05 and (n–1) degrees of freedom. While
still based on the assumption of normal distribution of
probe differences around a mean (“bias” or “offset”), this
method compensates for the size of the sample, includes
an adjustment for the expected differences in the mean,
and it is therefore more widely applicable than the large
sample approximation of (x ± 1.96 s).
Meta-analyses of data from the studies were performed
to calculate the overall mean difference between simul-
taneous ICP measurements and the variability. In calcu-
lating the overall mean difference across the combined
studies, results from individual studies were weighted,
assigning the weights using two standard approaches: a
fixed effects model and a random effects model.
A fixed effects approach assumes there is one true
mean ICP difference between paired probe values. The
overall mean difference is calculated by weighting indi-
vidual study results by the inverse of the observed
variance. The random effects approach assumes that the
true mean ICP difference between paired probes can
vary from one study to another. The overall mean
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difference is calculated by weighting individual studies
according to within-study and between-study variability.
Summary statistical analysis was done using the soft-
ware program SPSS (Version 21, IBM/SPSS, Inc.) and
for meta-analyses we used the software package Com-
prehensive Meta Analysis (Version 2.2.064, Biostat, Inc.).
Results
The literature search identified 163 studies; 80 were
excluded because they were not related to the aim of this
study. Of the remaining 83, only 64 reported compari-
sons of two paired intracranial catheters (Fig. 1).
Accuracy
After studies based on catheters placed in the epidural
space, or comparing the infratentorial and supratentorial
spaces, or with inadequate data reporting were excluded,
10 articles were left for accuracy analysis (Fig. 1). They
reported 15 studies, 10 in Group 1, and 5 in Group 2.
The main features of the studies are reported in Table 1,
including details on calibration of solid probes before
insertion, and zeroing of ventricular fluid-filled cathe-
ters. Calibration and/or VFC zeroing maneuvers were
reported in the vast majority of Group 1 studies,
whereas in Group 2 these maneuvers were less accur-
ately or not reported at all. ICP recordings for individual
studies covered a wide range (up to 100 mmHg) and all
studies included cases with ICP >20 mmHg. Limits of
agreement for individual studies are summarized in
Table 2.
Both positive and negative differences between probes
were observed in individual studies. The combined esti-
mate is a positive difference for probe 1 minus probe 2
readings, partly because of the ordering of the probes in
the calculation. All comparisons of the two locations in
Group 1 were standardized so that the difference was
always parenchymal–ventricular, leaving only one study
with negative differences (Table 1). For other paired
readings between catheters in similar locations (paren-
chymal–parenchymal or ventricular–ventricular), the
catheter with the highest average reading was identified
as probe 1, so as to give consistent positive (and not
offsetting) mean differences. The combined mean differ-
ence between probes, using a fixed model,was 0.9 mmHg,
with a 95 % confidence interval (CI) for the mean of
0.4–1.5 mmHg across Group 1 studies and 1.8 mmHg
Table 1 Main features of the studies included in the meta-analysis
Author/year of
publication
Probe 1 Probe 2 Probe
placement
Patients (n) Calibration/
zeroinga
Mean
difference
Standard
deviation
Correlation Datab
Group 1
1 Schickner 1992 [4] Camino VFC P–V 10 +/+ 9.20 7.80 NA Reported
2 Chambers 1993 [21] Camino VFC V–V 10 +/+ (EAM) 1.43 2.26 0.98 Calculated
3 Statham 1993 [22] Camino VFC P–V 11 +/+ 2.73 4.22 0.98 Reported
4 Gopinath 1995 [23] Codman VFC V–V 25 +/+ 0.50 2.60 0.97 Reported
5 Signorini 1998-2 [24] Codman VFC P–V 2 +/+ (EAM) 1.81 3.75 NA Calculated
6 Chambers 2001 [25] Spiegelberg VFC P–V 11 +/+ (EAM) 0.10 4.99 NA Reported
7 Koskinen 2005 [8] Codman VFC P–V 22 +/+ (EAM) 1.20 3.32 0.79 Reported
8 Lescot 2011-1 [26] Pressio VFC P–V 15 +/+ (EAM) –0.60 3.83 NA Reported
9 Lescot 2011-2 [26] Codman VFC P–V 15 +/+ (EAM) 0.30 3.52 NA Reported
10 Eide 2012-2 [18] Codman VFC P–V 5 NA/NA 4.52 13.97 NA Calculated
Group 2
11 Signorini 1998-1 [24] Codman Camino P–P 5 + 1.58 3.36 NA Calculated
12 Sahuquillo 1999-1 [2] Camino Camino P–P 33 NA 1.80 1.10 0.95 Reported
13 Sahuquillo 1999-2 [2] Camino Camino P–P 16 NA 7.50 6.40 0.85 Reported
14 Eide 2012-1 [18] Codman Codman P–P 5 NA 0.64 5.59 NA Calculated
15 Eide 2012-3 [18] Codman Spiegelberg P–P 7 + 0.70 2.63 NA Calculated
Studies comparing simultaneous readings from at least two catheters for intracranial pressure monitoring classified depending on the reported use (Group 1) or
not use (Group 2) of a reference standard (i.e.VFC) and reported in chronological order. Some papers reported more than one study; four are cited repeatedly. In
two studies a single catheter was placed in the ventricles (V-V). This gave a typical reading through a fluid-filled system and a simultaneous measurement through
a solid transducer at the tip
aDescription of calibration (of the solid probe) and zeroing (of the ventricular fluid-filled catheter). (+) Calibration or zeroing is reported, (++) both calibration and
zeroing are reported; NA information on calibration and zeroing maneuvers not available, (EAM) zeroing described at the external auditory meatus
bIndicates how the mean intracranial pressure differences between probes and standard deviations were determined (see Methods)
NA Not Available, P Parenchymal, V Ventricular, VFC Ventricular Fluid-Coupled catheter with external transducer
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Fig. 1 Flow diagram summarizing article selection; 83 articles were identified:64 reported accuracy, 37 reported drift (some reported both).
Articles on animals, with probes placed in the epidural, subdural, or infratentorial spaces and with inadequate data reporting were excluded.
High-quality articles on drift reported the range, mean and median of drift; the 17 papers refer to 20 studies. High-quality articles on accuracy
included comparisons of two ICP probes, with Bland-Altman analysis and adequate data reporting; the 10 papers listed refer to 15 studies
Table 2 Limits of agreement of the studies included in the meta-analysis
Author and year of publication Patients (n) Lower limit of agreement Mean difference Upper limit
of agreement
Group 1
1 Schickner 1992 [4] 10 −9.31 9.20 27.71
2 Chambers 1993 [21] 10 −3.92 1.43 6.78
3 Statham 1993 [22] 11 −7.09 2.73 12.55
4 Gopinath 1995 [23] 25 −4.97 0.50 5.97
5 Signorini 1998-2 [24] 5 −9.58 1.81 13.21
6 Chambers 2001 [25] 11 −11.51 0.10 11.71
7 Koskinen 2005 [8] 22 −5.86 1.20 8.26
8 Lescot 2011-1 [26] 15 −9.08 –0.60 7.88
9 Lescot 2011-2 [26] 15 −7.50 0.30 8.10
10 Eide 2012-2 [18] 5 −37.97 4.52 47.01
Group 2
11 Signorini 1998-1 [24] 5 −8.65 1.58 11.82
12 Sahuquillo 1999-1 [2] 33 –0.47 1.80 4.07
13 Sahuquillo 1999-2 [2] 16 −6.56 7.50 21.56
14 Eide 2012-1 [18] 5 −16.37 0.64 17.65
15 Eide 2012-3 [18] 7 −6.17 0.70 7.57
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(95 % CI 1.5–2.2 mmHg) across Group 2 studies. The
combined mean difference between all probes, assuming
the fixed model, was 1.6 mmHg (95 % CI 1.3–1.9 mmHg)
(Fig. 2).
The combined mean difference between probes, using
a random model, was 1.2 mmHg (95 % CI 0.2–
2.1 mmHg) in Group 1 studies and 2.3 mmHg (95 % CI
0.5–4.2 mmHg) in Group 2 studies. The combined mean
difference between all probes, pooling all studies and as-
suming the random effects model, was 1.5 mmHg (95 %
CI 0.7–2.3 mmHg) (Fig. 2).
Zero drift
The zero drift analysis was reported in 37 articles but
only 17 had adequate data reporting (Table 3). Although
some papers reported a wide range of values, the mean
drift over a long observation period was 0.75 mmHg.
No differences were detected between fiberoptic
probes and microstrain-gauge probes (mean fiberoptic
0.59 ± 1.8; mean microstrain-gauge 0.95 ± 0.23; p = 0.8),
or between data from clinical and laboratory studies
(clinical mean 0.81 ± 0.83; laboratory mean 0.48 ± 0.63;
p = 0.82).
Eleven papers addressed the degree of drift as a func-
tion of the duration of use; ten found no correlation
while one [17] described a weak positive correlation
(Spearman’s correlation coefficient 0.342; p = 0.001).
Discussion
This review found that when two ICP measurements
were taken simultaneously using different sensors the
averages were close, but with a large standard deviation.
The 10 studies in Group 1 compared various sensors to
ventricular catheters. Ventricular catheters are connected
through a fluid-filled system (VFC) to an external
transducer, which can be zeroed at will, offering a reliable
reference standard. The calculation of the average ICP dif-
ference in Group 1 included both positive and negative
values, which may have reduced the final picture (the ab-
solute difference).
While the majority of studies indicated only small
differences between the intraparenchymal probe and the
VFC, two reported widely differing ICP levels. Schickner
et al. [4] studied 10 patients with refractory ICP. They
used a Camino fiberoptic probe, and a ventricular cath-
eter was inserted to drain CSF. The Camino readings, on
average, were 9 mmHg higher than the VFC, with single
episodes of 40 mmHg difference. Eide et al. [18] retro-
spectively studied patients after subarachnoid or intra-
parenchymal bleeding. In five cases a Codman catheter
was compared with simultaneous readings by VFC; dif-
ferences were greater than 10 mmHg in three cases, and
one single case had large differences in all measure-
ments, with negative ICP. The authors suggested that
significant human errors in zeroing, or sensor damage,
may have occurred.
Group 2 comprised five studies comparing parenchy-
mal probes without a ventricular catheter as a standard
reference. Often these papers were published in order to
prove the existence of ICP gradients, and it is therefore
not surprising that they found a striking mean difference
[2]. Additionally, in this group all differences were posi-
tive, so there were no negative values to offset the final
average. This may explain why the mean differences
were slightly larger, but still only around 1–2 mmHg.
To sum up all the studies, we used both a fixed model
and a random model. Although all the studies involved a
comparison of simultaneous ICP measurements, the
populations were not homogeneous. They reflected a
cross-section of clinical cases, with differences in the
Fig. 2 Meta-analysis. Meta-analysis data with the corresponding forest plot for individual data sets (combined Groups 1 and 2). The black horizontal
line divides Group 1 (above) from Group 2 (below) studies, as reported in methods. CI Confidence Interval
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manufacturer and type of sensor used, the sensor place-
ment, and the type and extent of brain injury. Since all
these factors can potentially affect ICP measurements, it
cannot be assumed that all the studies were investigating
an unknown but constant difference between paired ICP
readings. We therefore feel that the assumptions for the
random effects model are more appropriate. Nonetheless,
the results with both models were closely comparable.
According to the random model, the combined mean
difference between probes was 1.5 mmHg, with a 95 %
CI of 0.7–2.3 mmHg. The simple pooled estimate of
the standard deviation (unweighted) across the 15 data
sets was 4.4 mmHg. Based on this estimate, a future
study (similar to the average composition of the 15
studies examined) comparing two simultaneous ICP
readings would be expected to have 95 % of the ob-
served differences in the interval 1.5 ± (2 × 4.4) mmHg.
Using the random standard error from the meta-
analysis, which includes between-study variability, this
interval would be slightly higher at 1.5 ± (2 × 5.7)
mmHg. According to the random effects model, 70 %
of readings could therefore vary in the range of
±6 mmHg, and 95 % of readings in the range of
±11.4 mmHg.
Discrepancies can be “true”, when there are pressure
differences in the various areas of the brain, or due to
inaccurate readings. True differences, when intracranial
gradients are caused by expanding masses or unilateral
hemorrhages, call for clinical judgment. In clinical rou-
tine, ICP is monitored with a single catheter in the over-
whelming majority of patients. In case of unilateral
masses with large shift, pressure gradients ( with higher
pressure on the lesion side) are possible. In this situation
the ICP data have to be interpreted considering where
the catheter is placed. Inaccurate readings due to tech-
nical problems are more worrying since they are not due
to actual intracranial gradients (and cannot be suspected
in the computed tomography scan) but to erroneous
measurement. Judging from the results of the meta-
analysis, true discrepancies are relatively rare, but may
be significant, up to ±11.4 mmHg. Clinicians should
always carefully analyze the monitored data and also
Table 3 Main features of the studies reporting drift
Author and year of publication Probe type Readings (n)a Test duration (days) ICP range (mmHg)
Clinical studies
1 Statham 1993 [22] Fiberoptic 11 1–11 0/+4
2 Bavetta 1997 [27] Fiberoptic 83 1–12 −12/+14
3 Münch1998 [28] Fiberoptic 95 1–17 −15/+12
4 Martines-Mañas 2000 [29] Fiberoptic 56 1–12 −24/+35
5 Poca 2002 [19] Fiberoptic 126 1–11 −12/+7
6 Stendel 2003-1 [17] Fiberoptic 50 1–32 0/+12
7 Gelabert-González 2006 [9] Fiberoptic 624 1–5 −17/+21
8 Gopinath 1995 [23] Microstrain gauge 25 2–7 −2/+2
9 Stendel 2003-2 [17] Microstrain gauge 98 3–28 −2/+3
10 Koskinen 2005 [8] Microstrain gauge 128 1–16 −5/+4
11 Citerio 2008 [30] Microstrain gauge 89 1–10 −4/+8
12 Al-Tamimi 2009 [20] Microstrain gauge 88 3; 6b NA
13 Lang 2003 [31] Microstrain gauge 84 3–28 −2/+2
Laboratory studies
14 Czosnyka 1996-1 [32] Fiberoptic 1 3 −0.8/+0.8
15 Czosnyka 1996-2 [32] Fiberoptic 1 3 −0.4/+0.4
16 Piper 2001 [33] Fiberoptic 34 1–12 −13/+22
17 Sundbӓrg 1987 [12] Microstrain gauge 1 3 −2/+2
18 Czosnyka 1996-3 [32] Microstrain gauge 1 3 −0.8/+0.8
19 Morgalla 1999 [10] Microstrain gauge 7 10 −4/+3
20 Citerio 2004 [11] Microstrain gauge 10 5 0/+2
Studies reporting drift were classified according to the setting (clinical or laboratory). Some papers reported more than one study; one paper is cited three times.
Since different probes were analyzed in some studies, a single reference may appear more than once
aIndicates how many readings of drift were used to calculate the range, mean and/or median (see text for more details)
bThe study by Al-Tamimi et al. included data from two centers and reported the median observation time for both
ICP Intracranial pressure, NA Not available
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look at trends, possibly in the context of multimodal
monitoring.
Fluid-coupled catheters can be re-zeroed as often as
necessary while other sensors, in which zeroing cannot
be repeated after insertion, may become less precise over
time. Zero drift has been reported for several catheters
under clinical and laboratory conditions [8–11, 19]. We
found the mean drift was limited (on average less than
1 mmHg); however, single catheters varied widely. In
general the pressures were within the limits specified by
the manufacturers. There seem to be no significant
differences between the various probes in clinical and
experimental studies. All papers but one [20] showed
no clear correlation between drift and length of ICP
monitoring. We can therefore assume that drift is not
related to the duration of monitoring, as previously
indicated [7].
Our review, pooling different studies often with differ-
ent designs, has limitations. The bulk of evidence on this
topic is also fairly old: the median year of publication of
studies on accuracy was 1998, and the range 1992–2012;
for studies on drift the median year of publication was
2001 (range 1987–2009). The standards for publication
have improved with time, with the result that recent
studies provided more comprehensive information com-
pared to the old ones.
Conclusions
The clinical implications of our findings may be relevant
both for future comparisons and for daily care. ICP
monitoring is widely used to guide diagnostic and thera-
peutic decisions, so it is essential to know how reliable
are the current techniques. The latest update of the
Brain Trauma Foundation guidelines [7] concluded that
parenchymal transducer devices measure ICP similarly
to VFC but have the potential for differences. Our find-
ings confirm that the average error is clinically negli-
gible, but the interval of error is wide.
Key messages
 A systematic literature review and meta-analysis
indicates that the average error between
simultaneous ICP measures is small (in the order
of 1.5–1.6 mmHg), but in 30 % of readings it
could exceed ±6 mmHg
 When there are intracranial gradients due to
expanding masses or unilateral hemorrhages, there
are likely to be larger differences between separate
ICP measures.
 In the absence of intracranial gradients, the risk of
inaccurate measurement seems rare.
 These findings are important both for future
comparisons studies and for daily care.
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